Authors
Loading...
Randomized trial investigates the effects of SPV106 on cardiac mesenchymal cells in type 2 diabetes, suggesting potential therapeutic implications.
Vecellio et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: